Cambridge Polymer Group (CPG) is delighted to announce that it has achieved for Polymers Contract Research, Extractables & Leachables Analytical Testing, and the Sales of Customized Bio-Medical Materials.
For more than three decades, CPG has worked with medical device, life sciences, and healthcare organizations to address complex materials challenges. Our scientists and engineers combine polymer science, analytical testing, and biomedical materials expertise to help customers understand material behavior, investigate product performance issues, navigate the testing requirements of regulatory pathways and make informed decisions.
“Our customers rely on us to help answer difficult scientific and technical questions, and to support their activities from concept through to manufacturing,” said Gavin Braithwaite, CEO of Cambridge Polymer Group. “Achieving ISO 13485 certification, in addition to ISO 9001 and ISO 17025, reflects the strength of our quality systems and the rigor, discipline, and care behind the work we do every day. For customers in the medical device industry, it provides additional confidence that the work supporting their projects is performed within a quality system designed to meet the requirements of that industry.”
ISO 13485 is the internationally recognized quality management system standard for organizations serving the medical device industry. The certification applies to CPG’s activities in:
- Polymers Contract Research
- Extractables & Leachables Analytical Testing
- Sales of Customized Bio-Medical Materials
The certification reflects the systems and processes that support our work every day. From material evaluation and scientific analysis to biomedical materials development, we remain focused on providing reliable results and insights that help customers move projects forward with confidence.
We would like to thank our employees whose dedication made this achievement possible and our customers for their continued trust and partnership.